Covered recipient · General Payments record
MICHIKO K BRUNO
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$4,936.24
- Reported across 93 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $644.22 | 33 |
| Education | $99.49 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| EISAI INC. | $166.37 | 3 |
| PFIZER INC. | $161.00 | 17 |
| ABBVIE INC. | $129.13 | 5 |
| Teva Pharmaceuticals USA, Inc. | $121.74 | 2 |
| Genentech USA, Inc. | $47.72 | 2 |
| Brainlab, Inc. | $47.46 | 1 |
| Amgen Inc. | $40.44 | 2 |
| Amneal Pharmaceuticals LLC | $24.19 | 1 |
| INSIGHTEC,INC | $5.66 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.25 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103382757 | CMS |
| ABBVIE INC. | $26.48 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103382759 | CMS |
| ABBVIE INC. | $25.60 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103382761 | CMS |
| ABBVIE INC. | $30.82 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103382763 | CMS |
| ABBVIE INC. | $28.98 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103382765 | CMS |
| Amgen Inc. | $16.13 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115466524 | CMS |
| Amgen Inc. | $24.31 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115466531 | CMS |
| Amneal Pharmaceuticals LLC | $24.19 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139181471 | CMS |
| Brainlab, Inc. | $47.46 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137066207 | CMS |
| Eisai Inc. | $125.00 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110766763 | CMS |
| Eisai Inc. | $19.04 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110766767 | CMS |
| Eisai Inc. | $22.33 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110766765 | CMS |
| Genentech USA, Inc. | $20.18 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133072801 | CMS |
| Genentech USA, Inc. | $27.54 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133072805 | CMS |
| InSightec,Inc | $5.66 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110445363 | CMS |
| PFIZER INC. | $23.13 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131161575 | CMS |
| PFIZER INC. | $8.86 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130903236 | CMS |
| PFIZER INC. | $4.00 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130904337 | CMS |
| PFIZER INC. | $1.46 | 03/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130902879 | CMS |
| PFIZER INC. | $5.14 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130908010 | CMS |
| PFIZER INC. | $1.37 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130909290 | CMS |
| PFIZER INC. | $18.26 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131628789 | CMS |
| PFIZER INC. | $0.31 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130946706 | CMS |
| PFIZER INC. | $9.72 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130949461 | CMS |
| PFIZER INC. | $24.07 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131880969 | CMS |
| PFIZER INC. | $0.28 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130993891 | CMS |
| PFIZER INC. | $22.35 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132091268 | CMS |
| PFIZER INC. | $9.72 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131091546 | CMS |
| PFIZER INC. | $1.87 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131039511 | CMS |
| PFIZER INC. | $22.32 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131055834 | CMS |
| PFIZER INC. | $0.28 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131007998 | CMS |
| PFIZER INC. | $7.86 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131156028 | CMS |
| Teva Pharmaceuticals USA, Inc. | $99.49 | 07/18/2024 | Education | Undisputed | 01/23/2026 | 1151593449 | CMS |
| Teva Pharmaceuticals USA, Inc. | $22.25 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151593515 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.